Skip to content
Ask about our Sudoscan Trade-in Program
  • About SUDOSCAN®
    • Enhancing Patient Care
    • Transformative Benefits of SUDOSCAN for Patients
    • The Value of Replacing Smart Electrodes
    • Long-term monitoring using SUDOSCAN®.
    • Reimbursement Regulatory
  • Our Company
    • For Physicians
    • For Patients
  • Medical Articles
  • SUDOSCAN® vs. Competition
    • SUDOSCAN® vs. Vitalscan Sudocheck Unveiling Key Differences in Durability, Efficiency, and Validation
    • The Power of SUDOSCAN® Patents vs. Patent Pending - Vitalscan Sudomotor
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
  • Log in
  • YouTube
  • LinkedIn
Cart
Subtotal
$0.00
Shipping, taxes, and discount codes calculated at checkout.
Your cart is currently empty.
Refundable Security Deposit for Sudoscan Refundable Security Deposit for Sudoscan Sudoscan Logo white Sudoscan Logo white
  • About SUDOSCAN®
    • Enhancing Patient Care
    • Transformative Benefits of SUDOSCAN for Patients
    • The Value of Replacing Smart Electrodes
    • Long-term monitoring using SUDOSCAN®.
    • Reimbursement Regulatory
  • Our Company
    • For Physicians
    • For Patients
  • Medical Articles
  • SUDOSCAN® vs. Competition
    • SUDOSCAN® vs. Vitalscan Sudocheck Unveiling Key Differences in Durability, Efficiency, and Validation
    • The Power of SUDOSCAN® Patents vs. Patent Pending - Vitalscan Sudomotor
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
account Log in icon-bag-minimalCart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
above vantage point of hands on hand docks

Comparing Sudoscan to other Diagnostic methods.

SUDOSCAN® vs. Competition


Comparison with other tests

Punch (skin) biopsy – IENFD

What it is: A 3-mm skin punch biopsy used to quantify intraepidermal nerve fiber density (IENFD).

Evidence and Role: “Distal leg skin biopsy… is a reliable and efficient technique to assess the diagnosis of SFN.”

(Level A)Safety: “3-mm skin biopsy at the ankle is a safe procedure… [with] 0.19% incidence of non-serious side effects.”

Comparison: Highly specific and objective, but invasive and less practical for frequent monitoring.
SUDOSCAN, being non-invasive, is better suited for regular screening or follow-up.

QSART (Quantitative Sudomotor Axon Reflex Test)

What it is: Uses cholinergic iontophoresis to measure postganglionic sudomotor function.

Core physiology: “QSART measures the postganglionic sudomotor response.”

Limitations: “QSART is also time-consuming, requires special equipment and is not widely available.”

Comparison: QSART is physiologically precise but resource-intensive. 

SUDOSCAN offers a faster, clinic-friendly sudomotor test.

SSR (Sympathetic Skin Response)

What it is: Measures evoked electrodermal potentials reflecting sympathetic cholinergic activation.

Sensitivity caveat: “Considering its low sensitivity, SSR should not be used as the only test to confirm sensory small fibre neuropathy.”

Comparison: SSR is easy to perform but less sensitive. 

SUDOSCAN delivers an objective, quantitative, reproducible sudomotor measurement.

QST (Quantitative Sensory Testing)

What it is: Assesses thermal and mechanical detection thresholds through patient response.

Limitations: “Quantitative sensory tests are psychophysical in nature, requiring cooperation from the patient.” And: “QST is a psychophysical test and lacks the objectivity of NCS.”

Comparison: QST helps characterize sensory gain/loss but is subjective.

 SUDOSCAN is objective, operator-independent, and less influenced by patient variability.

EMG (Electromyography)

What it is: Measures the electrical activity of muscles at rest and during contraction, typically via needle electrodes, to evaluate motor nerve and muscle health.

Clinical role: “Electromyography (EMG) is used to assess the health of muscles and the nerve cells that control them (motor neurons).”

Limitations for SFN: EMG primarily detects large fiber or motor involvement; “EMG and nerve conduction studies are often normal in patients with small fiber neuropathy.”

Comparison: EMG is valuable for ruling out other neuropathies and neuromuscular disorders but has low sensitivity for SFN. 

SUDOSCAN directly evaluates small autonomic fibers, making it complementary rather than competitive.

  • Biopsy (IENFD): Objective gold standard for SFN but invasive.
  • QSART: Specific but “time-consuming” and limited in availability.
  • SSR: Easy but “low sensitivity.”
  • QST: Useful but “psychophysical… requiring cooperation.”
  • EMG: Essential for large fiber/motor assessment but “often normal” in SFN.
  • SUDOSCAN: “Quick and non-invasive… within 3 minutes,” making it an ideal screening and monitoring tool that complements or replaces other diagnostic methods.
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube
  • LinkedIn

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • SUDOSCAN® vs. Competition
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop

Shop SUDOSCAN

  • Login
  • Create account
  • SUDOSCAN® Shop

Resources

  • For Physicians
  • Reimbursement Regulatory
  • Approved Cleaning Products
  • For Patients
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • SUDOSCAN® Articles
  • SUDOSCAN® Patient Marketing Materials

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.sudoscan.com

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

Privacy Policy | Terms of Services

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Visa
© 2025 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Powered by Shopify
SUDOSCAN vs Competition: Discover the Benefits